PubRank

E Louis

Author PubWeight™ 77.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Aligning conservation priorities across taxa in Madagascar with high-resolution planning tools. Science 2008 5.07
2 Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996 4.09
3 Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab? Aliment Pharmacol Ther 2012 2.74
4 Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology 2012 2.26
5 Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease. Scand J Gastroenterol 2001 1.72
6 Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine. Gut 2003 1.66
7 Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease. Aliment Pharmacol Ther 2004 1.62
8 Olfaction in Parkin heterozygotes and compound heterozygotes: the CORE-PD study. Neurology 2010 1.57
9 Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut 1999 1.55
10 Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997 1.52
11 The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun 2007 1.50
12 Risk of Alzheimer's disease in relatives of Parkinson's disease patients with and without dementia. Neurology 1999 1.48
13 Risk of Parkinson's disease among first-degree relatives: A community-based study. Neurology 1996 1.30
14 Transpedicular screw placement: image-guided versus lateral-view fluoroscopy: in vitro simulation. Spine (Phila Pa 1976) 2001 1.25
15 Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 1999 1.25
16 Traumatic separation of the distal femoral epiphyseal cartilage plate. J Bone Joint Surg Am 1974 1.25
17 Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis. J Crohns Colitis 2011 1.18
18 The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies. Aliment Pharmacol Ther 2010 1.18
19 Intraventricular cavernomas: three cases and review of the literature. Neurosurgery 1999 1.16
20 Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil 2009 1.07
21 Commentary: predicting complicated Crohn's disease and surgery--phenotypes, genetics, serology and psychological characteristics of a population-based cohort. Aliment Pharmacol Ther 2013 1.06
22 Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group. Am J Gastroenterol 1999 1.04
23 Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease. Am J Gastroenterol 2002 1.03
24 Video capsule endoscopy in small-bowel malignancy: a multicenter Belgian study. Endoscopy 2006 1.02
25 Serum calprotectin as a biomarker for Crohn's disease. J Crohns Colitis 2013 1.02
26 Cytokine production from sputum cells after allergenic challenge in IgE-mediated asthma. Allergy 2002 1.02
27 The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab. Aliment Pharmacol Ther 2010 0.97
28 Profile of soluble cytokine receptors in Crohn's disease. Gut 2005 0.97
29 Environmental risk factors for Parkinson's disease in an urban multiethnic community. Neurology 1998 0.94
30 Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul Pept 1998 0.91
31 Clinical pattern of corticosteroid dependent Crohn's disease. Eur J Gastroenterol Hepatol 1998 0.88
32 Efficiency of informational transfer in regular and complex networks. Phys Rev E Stat Nonlin Soft Matter Phys 2005 0.88
33 Lack of association between adult asthma and the tumour necrosis factor alpha-308 polymorphism gene. Eur Respir J 2000 0.87
34 Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. Clin Exp Immunol 2004 0.85
35 [Frontal sinus osteomas: neuro-ophthalmological complications]. Neurochirurgie 2002 0.85
36 Profile of pediatric Crohn's disease in Belgium. J Crohns Colitis 2013 0.84
37 Development of adenocarcinoma in chronic fistula in Crohn's disease. Acta Gastroenterol Belg 2005 0.84
38 Cytokine production from peripheral whole blood in atopic and nonatopic asthmatics: relationship with blood and sputum eosinophilia and serum IgE levels. Allergy 2000 0.84
39 Are neurons multifractals? J Neurosci Methods 1999 0.83
40 Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003. Acta Gastroenterol Belg 2006 0.83
41 Phase characterization of the reflection on an extreme UV multilayer: comparison between attosecond metrology and standing wave measurements. Opt Lett 2011 0.82
42 Highly efficient blazed grating with multilayer coating for tender X-ray energies. Opt Express 2016 0.82
43 Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission. Int J Colorectal Dis 2000 0.82
44 Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease. Acta Gastroenterol Belg 2003 0.82
45 Evolution and predictive factors of relapse in ulcerative colitis patients treated with mesalazine after a first course of corticosteroids. J Crohns Colitis 2011 0.81
46 Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures. Dig Dis Sci 1999 0.81
47 Corticosteroid treatment in active Crohn's disease. Acta Gastroenterol Belg 1998 0.81
48 Incidence of inflammatory bowel disease in the area of Liège: a 3 years prospective study (1993-1996). Acta Gastroenterol Belg 1999 0.81
49 First-principles phase-coherent transport in metallic nanotubes with realistic contacts. Phys Rev Lett 2003 0.81
50 Skeletal muscle plasticity with marathon training in novice runners. Scand J Med Sci Sports 2011 0.81
51 Modelling single shot damage thresholds of multilayer optics for high-intensity short-wavelength radiation sources. Opt Express 2012 0.81
52 Altered expression of type I insulin-like growth factor receptor in Crohn's disease. Clin Exp Immunol 2005 0.80
53 Fundic argyrophil cell hyperplasia in atrophic gastritis: a search for a sensitive diagnostic method. Acta Gastroenterol Belg 1993 0.79
54 Respiratory work in relation to cardiopulmonary bypass. Thorax 1967 0.79
55 Use of the enteroscope for colo-ileoscopy: low yield in unexplained lower gastrointestinal bleeding. Endoscopy 1999 0.78
56 Familial Crohn's disease: a study of 18 families. Acta Gastroenterol Belg 1997 0.78
57 Single shot damage mechanism of Mo/Si multilayer optics under intense pulsed XUV-exposure. Opt Express 2010 0.78
58 Observational survey of NSAID-related upper gastro-intestinal adverse events in Belgium. Acta Gastroenterol Belg 2002 0.78
59 [Lynch syndrome and microsatellite instability: a review]. Rev Med Liege 2012 0.77
60 [Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory diseases of the digestive tract]. Acta Gastroenterol Belg 1994 0.77
61 Interactions between follicular dendritic cells and lymphoid cells. Adv Exp Med Biol 1988 0.77
62 Ultrastructural demonstration of histamine in human enterochromaffin like cell granules. Gut 1991 0.77
63 Hydroxychloroquine (Plaquenil) for recurrence prevention of Crohn's disease after curative surgery. Gastroenterol Clin Biol 1995 0.77
64 Effects of proglumide and enprostil on omeprazole-induced fundic endocrine cell hyperplasia in rats. Gastroenterol Clin Biol 1993 0.77
65 [Vedolizumab (Entyvio®) for the treatment of inflammatory bowel diseases]. Rev Med Liege 2015 0.76
66 Incidence of inflammatory bowel disease in the province of Liège (Belgium). La Société de Gastroentérologie Liègeoise. Acta Gastroenterol Belg 1996 0.76
67 Damage mechanisms of MoN/SiN multilayer optics for next-generation pulsed XUV light sources. Opt Express 2011 0.76
68 Systemic iron metabolism and mortality from Parkinson's disease. Neurology 1998 0.76
69 Foramen magnum syndrome secondary to calcium pyrophosphate crystal deposition in the transverse ligament of the atlas. Spine (Phila Pa 1976) 2001 0.76
70 Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease? Authors' reply. Aliment Pharmacol Ther 2013 0.75
71 Infliximab and the bone in Crohn's disease. Aliment Pharmacol Ther 2005 0.75
72 Thiopurine metabolites and TPMT activity measurement in inflammatory bowel disease. Aliment Pharmacol Ther 2011 0.75
73 Increased response of blood eosinophils to various chemotactic agents in quiescent Crohn disease. Scand J Gastroenterol 2001 0.75
74 High-reflectance La/B-based multilayer mirror for 6.x  nm wavelength. Opt Lett 2015 0.75
75 Strictureplasty in Crohn's disease: short- and long-term follow-up. Acta Chir Belg 2002 0.75
76 Initial medical management of severe acute ulcerative colitis. Acta Gastroenterol Belg 2001 0.75
77 [Barrett's esophagus: overview]. Rev Med Liege 2002 0.75
78 [Pathological implications in the neuroendocrine gastrointestinal system]. Rev Med Liege 2002 0.75
79 [Screening for colorectal cancer]. Rev Med Liege 2007 0.75
80 [Clinical case of the month. Extended portal vein thrombosis in patient on vitamin K antagonists]. Rev Med Liege 2013 0.75
81 Diagnosis of small bowel malabsorption syndromes in adults. Acta Gastroenterol Belg 2006 0.75
82 [Proteomics studies on arthritis by SELDI-TOF-MS: identification of the S100 proteins family as proteins of interest]. Rev Med Liege 2009 0.75
83 [Immunosuppressive treatment and Crohn's disease]. Rev Med Liege 1991 0.75
84 The medical management of severe acute and chronic ulcerative colitis--current recommendations from the Belgian Working Group. Acta Gastroenterol Belg 2001 0.75
85 [Digestive immune system and neuroendocrine peptides]. Rev Med Liege 1990 0.75
86 Ileo-caecal actinomycosis: report of a case simulating complicated inflammatory bowel disease. Acta Gastroenterol Belg 2002 0.75
87 Detecting determinism in high-dimensional chaotic systems. Phys Rev E Stat Nonlin Soft Matter Phys 2001 0.75
88 [RENDU-OSLER DISEASE: A RARE CAUSE OF AMMONIA ENCEPHALOPATHY]. Rev Med Liege 2016 0.75
89 [Food intolerance and allergy in the irritable bowel syndrome]. Rev Med Liege 2005 0.75
90 [Video-assisted thoracoscopic surgery]. Neurochirurgie 2001 0.75
91 Should patients under long-term anti-TNF therapies be followed for tuberculosis contamination? Inflamm Bowel Dis 2010 0.75
92 [Crohn's disease and MRI: assessment of inflammatory activity and tissue damage]. Rev Med Suisse 2013 0.75
93 [Chronic anemia in inflammatory bowel diseases: review]. Rev Med Liege 2005 0.75
94 [Colorectal cancer screening: an absolute necessity and a concrete reality in the French community]. Rev Med Liege 2009 0.75
95 [Primary and secondary prevention of colorectal cancer]. Rev Med Liege 2003 0.75
96 [Gastro-esophageal reflux and asthma]. Rev Med Liege 1999 0.75
97 Network community structure and loop coefficient method. Phys Rev E Stat Nonlin Soft Matter Phys 2006 0.75
98 [Optimal use of proton pump inhibitors in primary care]. Rev Med Liege 2014 0.75
99 [Treatment of Crohn disease in adults with tumor necrosis factor-alpha (TNF-alpha) antibodies]. Rev Med Liege 2000 0.75
100 A method for measuring precapillary bronchopulmonary artery blood flow. Ann Thorac Surg 1967 0.75
101 Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitis. J Crohns Colitis 2007 0.75
102 [FROM EVIDENCE-BASED MEDICINE TO PERSONALIZED MEDICINE IN CROHN'S DISEASE]. Rev Med Liege 2015 0.75
103 [Genetics of inflammatory bowel disease]. Bull Mem Acad R Med Belg 2010 0.75
104 [Intramedullary tumors. Results of a national investigation in private neurosurgery]. Neurochirurgie 2010 0.75
105 [Current salazosulfapyridine derivatives in the treatment of Crohn's disease]. Rev Med Liege 1991 0.75
106 [STRICTURING CROHN'S DISEASE: CLINICAL FEATURES, DIAGNOSIS AND TREATMENT]. Rev Med Liege 2016 0.75
107 Clinical and scientific aspects related to biosimilars in inflammatory bowel diseases (IBD): position document of the Belgian IBD Research & Development Group (BIRD). Acta Gastroenterol Belg 2015 0.75
108 [Asthma: a complex disease determined by genetic and environmental factors]. Rev Med Liege 2012 0.75
109 1/f Noise in sliding friction under wear conditions: the role of debris. Phys Rev Lett 2009 0.75
110 Bronchopulmonary precapillary blood flow during cardiopulmonary bypass. Am Heart J 1968 0.75
111 [Innovative therapies in inflammatory bowel disease at the CHU]. Rev Med Liege 2007 0.75
112 Persisting signs of disease activity at Magnetic Resonance Enterocolonography predict clinical relapse and disease progression in quiescent Crohn's disease. Acta Gastroenterol Belg 2015 0.75
113 Quasicrystalline and rational approximant wave patterns in hydrodynamic and quantum nested wells. Phys Rev Lett 2006 0.75
114 [Intracranial facial nerve schwannomas. Seven cases reviewed]. Neurochirurgie 2006 0.75
115 Performance Optimization of a High-Repetition-Rate KrF Laser Plasma X-Ray Source for Microlithography. J Xray Sci Technol 1992 0.75
116 Debris and 1/f noise in sliding friction dynamics under wear conditions. Phys Rev E Stat Nonlin Soft Matter Phys 2009 0.75
117 [Chronic subdural hematoma in patients over 80 years of age]. Neurochirurgie 1999 0.75
118 Kondo effect of an adsorbed cobalt phthalocyanine (CoPc) molecule: the role of quantum interference. Phys Rev Lett 2006 0.75
119 Spectral-purity-enhancing layer for multilayer mirrors. Opt Lett 2008 0.75
120 [Biologic therapies in chronic inflammatory bowel diseases]. Rev Med Liege 2009 0.75
121 Can model Hamiltonians describe the electron-electron interaction in π-conjugated systems?: PAH and graphene. J Phys Condens Matter 2015 0.75
122 Intestinal permeability in Crohn's disease. Acta Gastroenterol Belg 1996 0.75
123 Role of architecture in determining passive electrical properties in gap junction-connected cells. Pflugers Arch 2000 0.75
124 Safety and cost of infliximab for the treatment of Belgian pediatric patients with Crohn's disease. Acta Gastroenterol Belg 2012 0.75
125 Abdominal ultrasonography by the hepato-gastroenterologist: problems, demands, solutions. Acta Gastroenterol Belg 2011 0.75
126 Absolute brightness of laser plasmas in the soft-x-ray emission band. Appl Opt 1994 0.75
127 Anatomic basis for auditory brainstem implant. Surg Radiol Anat 1997 0.75
128 Properties of broadband depth-graded multilayer mirrors for EUV optical systems. Opt Express 2010 0.75
129 Infrared diffractive filtering for extreme ultraviolet multilayer Bragg reflectors. Opt Express 2013 0.75
130 [Enterochromaffin-like cells and their receptors: physiological role and physiopathological significance]. Acta Gastroenterol Belg 1994 0.75
131 [Video-capsule endoscopy for small bowel investigation]. Rev Med Liege 2004 0.75
132 [Leukocytic integrins: from molecular biology to immunopathology and immunoregulation]. Rev Med Liege 1989 0.75
133 [Pedoncular hallucinosis: implication of the thalamic and pontine structures]. Rev Neurol (Paris) 2001 0.75
134 [PPI very long-term treatment: is the problem only economic?]. Rev Med Liege 2006 0.75
135 Triggering synchronized oscillations through arbitrarily weak diversity in close-to-threshold excitable media. Phys Rev E Stat Nonlin Soft Matter Phys 2001 0.75
136 [Traumatic retroplacental hematomas]. Rev Fr Gynecol Obstet 1986 0.75
137 Non-Gaussian tails in the probability distribution function of heat exchanged during isothermal stretching of aluminum and gold nanowires. Phys Rev E Stat Nonlin Soft Matter Phys 2009 0.75
138 [Evolution in the therapeutic strategy of localized resectable pancreatic ductal adenocarcinoma]. Rev Med Suisse 2015 0.75
139 On the validity of the two-cells model in the analysis of passive electrical properties of gap-junction connected cells. Eur Biophys J 2001 0.75
140 Depth of remission in Crohn's disease patients seen in a referral centre : associated factors and impact on disease outcome. Acta Gastroenterol Belg 2014 0.75
141 Wavelength separation from extreme ultraviolet mirrors using phaseshift reflection. Opt Lett 2012 0.75
142 [Activity indices in Crohn's disease]. Rev Med Liege 1991 0.75
143 [Therapeutic update in gastroenterology]. Rev Med Liege 2007 0.75
144 [CRITICAL VIEWPOINT ON THE CURRENT APPROACH OF LOCALIZED PANCREATIC DUCTAL ADENOCARCINOMA]. Rev Med Liege 2015 0.75
145 [Neurostimulation in the treatment of chronic pain]. Neurochirurgie 2000 0.75
146 [Differential diagnosis of chronic diarrhoea]. Rev Med Liege 2014 0.75